Jiangsu Hengrui Pharmaceuticals company profile

600276 · SSE · CNY

Compare Jiangsu Hengrui Pharmaceuticals
¥47.00Change from previous close: +0.26%Absolute change: +¥0.12

Close · November 20, 2026

Company profile

Jiangsu Hengrui Pharmaceuticals has 20,602 employees and is headquartered in Lianyungang, China.

Patients and healthcare providers in China and abroad are the people Jiangsu Hengrui Pharmaceuticals serves with medicines it researches, develops, manufactures and commercializes to address clinical needs that remain unmet. Its medicines cover oncology, metabolic and cardiovascular diseases, immunological and respiratory conditions, neuroscience, pain management, infectious diseases, hematological disorders, ophthalmology and autoimmune illnesses, among other areas.

In the fiscal year ended December 2025, revenue reached 31.6 billion yuan, up 13% from the previous year, while net profit amounted to 7.7 billion yuan. The group employs 20,602 people and is headquartered in Lianyungang, China, where it was set up in 1970.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
China
Headquarters
No. 38, Huanghe Road, 222047, Lianyungang
Employees
20,602
Chief executive
Ji Feng
Founded
1970
Fiscal year
January - December
Listing
600276 · SSE
Currency
CNY
ISIN
CNE0000014W7

Jiangsu Hengrui Pharmaceuticals and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Jiangsu Hengrui Pharmaceuticals600276China$46.71B20,60227.4%35.1
Sun Pharmaceutical IndustriesSUNPHARMAIndia$48.8B47,00023.3%41.2
Divi's LaboratoriesDIVISLABIndia$32.03B11,56534.0%88.2
Takeda Pharmaceutical4502Japan$70.21B47,02916.6%312.4
Hansoh Pharmaceutical Group3692Hong Kong SAR China$23.77B9,64337.3%25.0
Torrent PharmaceuticalsTORNTPHARMIndia$19.25B18,25822.2%79.2

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Jiangsu Hengrui Pharmaceuticals with its competitors